Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company 2025-07-15 19:30
Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity 2025-07-15 07:00
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform 2025-07-14 15:38
CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO 2025-07-14 08:00
Angel Yeast Unveils 2024 Sustainability Report, Showcasing Commitment to Green Practices and Innovation 2025-07-11 15:18
Earendil Labs announces initiation of a phase 1 study of a half-life extended novel anti-TL1A antibody 2025-07-10 19:00
GenScript Biotech Earns EcoVadis Silver Medal, Ranking in Top 15% Globally for Sustainability 2025-07-09 20:32
Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial 2025-07-09 20:00
First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418 2025-07-09 11:14
LakeShore Biopharma Announces US$15 Million Private Placement Financing 2025-07-08 19:25
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities 2025-07-08 10:41
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo) 2025-07-08 10:08
WuXi AppTec Receives MSCI ESG AAA Leader Rating 2025-07-07 20:08
Nuevocor Strengthens Board with Appointment of Thierry Abribat 2025-07-07 13:00
ESG | HitGen Releases Its Inaugural Sustainability Report 2025-07-04 19:00
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results 2025-07-03 20:30
MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform 2025-07-03 18:07
So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement 2025-07-03 17:00
Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy 2025-07-03 14:46
Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2025-07-03 08:08
1 15 16 17 18 19 262